BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Pathophysiol. Sep 22, 2025; 16(3): 107954
Published online Sep 22, 2025. doi: 10.4291/wjgp.v16.i3.107954
Figure 1
Figure 1 Association of specific kirsten rat sarcoma viral oncogene homolog, neuroblastoma RAS viral oncogene homolog, and v-raf murine sarcoma viral oncogene homolog B1 hot-spot mutations with tumor’s pathological stage. A statistically significant at P < 0.05. Regression models were adjusted for age at diagnosis, sex, race/ethnicity, primary tumor site, DNA mismatch repair status, familial cancer risk, number of comorbidities, and tobacco use. BRAF: V-raf murine sarcoma viral oncogene homolog B1; KRAS: Kirsten rat sarcoma viral oncogene homolog; NC: Not calculated; NRAS: Neuroblastoma RAS viral oncogene homolog; CI: Confidence interval; OR: Odds ratio; pT: Pathological stage.
Figure 2
Figure 2 Association of specific kirsten rat sarcoma viral oncogene homolog, neuroblastoma RAS viral oncogene homolog, and v-raf murine sarcoma viral oncogene homolog B1 hot-spot mutations with regional lymph node and distant metastasis. A statistically significant at P < 0.05. Regression models were adjusted for age at diagnosis, sex, race/ethnicity, primary tumor site, DNA mismatch repair status, familial cancer risk, number of comorbidities, and tobacco use. BRAF: V-raf murine sarcoma viral oncogene homolog B1; KRAS: Kirsten rat sarcoma viral oncogene homolog; NC: Not calculated; NRAS: Neuroblastoma RAS viral oncogene homolog; CI: Confidence interval; OR: Odds ratio.